Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
THC Therapeutics, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.0032 |
52 Week High | US$0.0078 |
52 Week Low | US$0.000001 |
Beta | 103.31 |
1 Month Change | -41.82% |
3 Month Change | -47.54% |
1 Year Change | n/a |
3 Year Change | -99.00% |
5 Year Change | -99.97% |
Change since IPO | -99.84% |
Recent News & Updates
Recent updates
Shareholder Returns
THCT | US Medical Equipment | US Market | |
---|---|---|---|
7D | 0% | -2.9% | -3.2% |
1Y | n/a | -3.7% | 19.3% |
Return vs Industry: Insufficient data to determine how THCT performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how THCT performed against the US Market.
Price Volatility
THCT volatility | |
---|---|
THCT Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.4% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.5% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: THCT's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine THCT's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2007 | 1 | Scott Cox | thct.io |
THC Therapeutics, Inc. operates in the wellness industry. It engages in the developing of dHydronator, a sanitizing herb dryer for drying and sanitizing of freshly harvested cannabis, other herbs, flowers, and tea leaves. The company was formerly known as Millennium Blockchain, Inc. and changed its name to THC Therapeutics, Inc. in September 2018.
THC Therapeutics, Inc. Fundamentals Summary
THCT fundamental statistics | |
---|---|
Market cap | US$128.85k |
Earnings (TTM) | -US$387.04k |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.3x
P/E RatioIs THCT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
THCT income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$387.04k |
Earnings | -US$387.04k |
Last Reported Earnings
Jul 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0096 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | -23.9% |
How did THCT perform over the long term?
See historical performance and comparison